Warren Wasiewski, MD
Chief Medical Officer and Vice President of Research and Development
Warren Wasiewski, MD, is a board-certified pediatric neurologist with 22 years of clinical experience in pediatric neurology and 15 years of experience in the pharmaceutical industry. Most recently, Dr. Wasiewski was Chief Medical Officer and Executive Vice President of Clinical Development for Neurotrope BioScience, leading its Alzheimer’s disease program as well as 2 orphan indications. Prior to this, he was Vice President of Clinical Development for Neurology at Alexion Pharmaceuticals and, earlier, Senior Medical Director for AstraZeneca in Neurology. Dr. Wasiewski’s clinical career includes both academic and private practice as an Associate Professor of Pediatrics at Penn State Children’s Hospital and Chair of Pediatrics at Lancaster General Hospital. His pharmaceutical experience has spanned all aspects of drug development, including all 4 phases of clinical development, establishing global regulatory strategy, assessing business development opportunities and mergers, and raising capital to support clinical programs. Dr. Wasiewski has extensive clinical trial design experience and expertise, including study design for orphan indications.
Dr. Wasiewski has a BA from Rutgers College, an MS from State University of New York Downstate Medical Center, and an MD from State University of New York, Buffalo.Learn about other members of the Bioblast leadership team